Part natural killer, part T cell, this hybrid immune cell has a “double sword” for fighting cancer.

In her new role, Dr. Hsu will work to diversify matriculating classes and train students to become skilled leaders as both clinicians and biomedical researchers.

In the future, more-advanced genetic testing might offer better ways to match up patients who need a bone marrow transplant with potential donors.